Literature DB >> 2143630

Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone.

A F Perna1, G Z Fadda, X J Zhou, S G Massry.   

Abstract

Excess parathyroid hormone (PTH) in presence or absence of chronic renal failure impairs insulin release from pancreatic islets. This abnormality has been attributed to PTH-induced accumulation of Ca in the cytosol of the islets. Direct evidence for the latter phenomenon is lacking. This study examined the effect of chronic administration of PTH to rats with normal renal function on resting cytosolic Ca of the islets and evaluated the mechanisms through which a rise in resting cytosolic Ca may inhibit insulin secretion. After 42 days of PTH administration, glucose-induced insulin secretion was impaired, and this defect was corrected by the use of D-glyceraldehyde as secretagogue for insulin. Resting cytosolic Ca of islets from PTH-treated rats was markedly increased compared with that of islets from normal animals (288 +/- 27.1 vs. 135 +/- 3.7 nM, P less than 0.01), and their content of ATP in the presence of both 2.8 and 16.7 mM D-glucose was reduced (2.8 mM D-glucose, 4.6 +/- 0.17 vs. 6.0 +/- 0.42 pmol/islet, P less than 0.01; and 16.7 mM D-glucose, 6.9 +/- 0.25 vs. 11.1 +/- 0.95 pmol/islet, P less than 0.01). D-Glyceraldehyde increased ATP content in islets of PTH-treated rats from 4.6 +/- 0.17 to 8.8 +/- 0.71 pmol/islet. Glucose uptake by the islets, their insulin content, and both the Vmax and the apparent Km for fructose 6-phosphate of phosphofructokinase 1 (EC 2.7.1.11) in PTH-treated rats were not different from normal. The two major cellular derangements in the islets of PTH-treated rats were a reduction in ATP content and a rise in resting cytosolic Ca.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143630     DOI: 10.1152/ajprenal.1990.259.2.F210

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Update on glycemic control for the treatment of diabetic kidney disease.

Authors:  Girish N Nadkarni; Rabi Yacoub; Steven G Coca
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 2.  Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.

Authors:  Connie M Rhee; Kamyar Kalantar-Zadeh; Katherine R Tuttle
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-01-01       Impact factor: 2.894

3.  Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.

Authors:  Ch Sampanis
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

4.  Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity.

Authors:  E Kamycheva; R Jorde; Y Figenschau; E Haug
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

5.  On the mechanism of impaired insulin secretion in chronic renal failure.

Authors:  G Z Fadda; S M Hajjar; A F Perna; X J Zhou; L G Lipson; S G Massry
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 6.  Hormesis in Health and Chronic Diseases.

Authors:  Xin Li; Tingting Yang; Zheng Sun
Journal:  Trends Endocrinol Metab       Date:  2019-09-11       Impact factor: 12.015

7.  Parathyroid hormone suppresses insulin signaling in adipocytes.

Authors:  Eugene Chang; Shawn S Donkin; Dorothy Teegarden
Journal:  Mol Cell Endocrinol       Date:  2009-04-09       Impact factor: 4.102

8.  Effect of curative parathyroidectomy on insulin resistance.

Authors:  Rachel Putnam; Deba Prasad Dhibar; Shweta Varshney; Arunanshu Behera; B R Mittal; Anil Bhansali; Sudhaker D Rao; Sanjay Kumar Bhadada
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

Review 9.  Role of vitamin D in insulin resistance.

Authors:  Chih-Chien Sung; Min-Tser Liao; Kuo-Cheng Lu; Chia-Chao Wu
Journal:  J Biomed Biotechnol       Date:  2012-09-03

10.  Improving Glucose Homeostasis after Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism with Co-Existing Prediabetes.

Authors:  Spyridon Karras; Cedric Annweiler; Dimitris Kiortsis; Ioannis Koutelidakis; Kalliopi Kotsa
Journal:  Nutrients       Date:  2020-11-16       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.